Cargando…
A New Broad Range Plasmid for DNA Delivery in Eukaryotic Cells Using Lactic Acid Bacteria: In Vitro and In Vivo Assays
Lactococcus lactis is well documented as a promising candidate for development of novel oral live vaccines. It has been broadly engineered for heterologous expression, as well as for plasmid expression vector delivery, directly inside eukaryotic cells, for DNA vaccine, or as therapeutic vehicle. Thi...
Autores principales: | Mancha-Agresti, Pamela, Drumond, Mariana Martins, Carmo, Fillipe Luiz Rosa do, Santos, Monica Morais, Santos, Janete Soares Coelho dos, Venanzi, Franco, Chatel, Jean-Marc, Leclercq, Sophie Yvette, Azevedo, Vasco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363290/ https://www.ncbi.nlm.nih.gov/pubmed/28344994 http://dx.doi.org/10.1016/j.omtm.2016.12.005 |
Ejemplares similares
-
Vector Development Timeline for Mucosal Vaccination and Treatment of Disease Using Lactococcus lactis and Design Approaches of Next Generation Food Grade Plasmids
por: de Castro, Camila Prosperi, et al.
Publicado: (2018) -
Microencapsulation of Lactic Acid Bacteria Improves the Gastrointestinal Delivery and in situ Expression of Recombinant Fluorescent Protein
por: Coelho-Rocha, Nina D., et al.
Publicado: (2018) -
Lactococcus lactis FNBPA(+) (pValac:e6ag85a) Induces Cellular and Humoral Immune Responses After Oral Immunization of Mice
por: de Castro, Camila Prósperi, et al.
Publicado: (2021) -
Novel Strategies for Efficient Production and Delivery of Live Biotherapeutics and Biotechnological Uses of Lactococcus lactis: The Lactic Acid Bacterium Model
por: Tavares, Laísa M., et al.
Publicado: (2020) -
Neuroprotective effects of p62(SQSTM1)-engineered lactic acid bacteria in Alzheimer’s disease: a pre-clinical study
por: Cecarini, Valentina, et al.
Publicado: (2020)